Search company, investor...

Predict your next investment

HydraFacial company logo
Corporation
CONSUMER PRODUCTS & SERVICES | Personal / Salon Services
hydrafacial.com

Partners & Customers

10

About HydraFacial

HydraFacial Company is an FDA registered manufacturer of advanced aesthetic technologies and products that deliver high return on investment (ROI) opportunities. It provides ongoing, comprehensive marketing support to help increase customer's profitability.

Headquarters Location

2165 E Spring Street

Long Beach, California, 90806,

United States

800-603-4996

Are you an investor?
Submit your portfolio details now to be considered in our investor rankings.

Latest HydraFacial News

BEAUTY HEALTH ONGOING DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Beauty Health To Contact Him Directly To Discuss Their Options

Dec 10, 2023

Official THE BEAUTY HEALTH COMPANY press release BEAUTY HEALTH ONGOING DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Beauty Health To Contact Him Directly To Discuss Their Options December 10, 2023 at 10:16 am EST Share If you suffered losses exceeding $50,000 investing in Beauty Health securities between May 10, 2022 and November 13, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/SKIN. There is no cost or obligation to you. NEW YORK, Dec. 10, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against The Beauty Health Company ("Beauty Health" or the "Company") (NASDAQ: SKIN) and reminds investors of the January 16, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Pennsylvania, California and Georgia. As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) that Syndeo 1.0 and 2.0 devices had issues leading to "frequent treatment interruptions;" (2) that, as a result, the Company incurred significant costs to develop enhancements; (3) that, despite the enhancements, providers continued to experience issues with the Syndeo devices; (4) that, as a result, the Company would no longer market Syndeo 1.0 and 2.0 devices and incur significant inventory writedowns; (5) that, as a result, the Company's profitability would be adversely impacted; and (6) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. On August 9, 2023, before the market opened, Beauty Health announced that second quarter 2023 gross margin was "unfavorably impacted" by a mix shift "toward lower-margin refurbished devices . . . as U.S. providers awaited Syndeo enhancements in the third quarter 2023 to improve user experience." The Company also announced the "involuntary separation without cause" of Chief Financial Officer ("CFO") Liyuan Woo. On this news, the Company's shares fell $0.41, or 5.4%, to close at $7.12 per share on August 9, 2023, on unusually heavy trading volume. Then, on November 13, 2023, after the market closed, Beauty Health announced its financial results for the third quarter of 2023. The Company disclosed that "[t]he quarter was overshadowed by lower-than-expected U.S. revenue and $63.1 million in restructuring charges related to device upgrades of early generation Syndeo devices." As a result, "the Company is revising its fiscal year 2023 net sales guidance to a range of $385 to $400 million, its fiscal year adjusted EBITDA margin guidance to a range of 5% to 6% and is suspending its long-term 2025 financial outlook." The Company further disclosed that Andrew Stanleick would depart the Company as President & Chief Executive Officer ("CEO") and relinquish his Board seat, effective November 19, 2023. On this news, the Company's share price fell $2.51, or 64.36%, to close at $1.39 per share on November 14, 2023, on unusually heavy trading volume. The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. Faruqi & Faruqi, LLP also encourages anyone with information regarding Beauty Health's conduct to contact the firm, including whistleblowers, former employees, shareholders and others. Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner. View original content to download multimedia:https://www.prnewswire.com/news-releases/beauty-health-ongoing-deadline-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-50-000-in-beauty-health-to-contact-him-directly-to-discuss-their-options-302010638.html SOURCE Faruqi & Faruqi, LLP The Beauty Health Company is a category-creating company that delivers beauty health experiences. Its flagship brand, HydraFacial, has created the category of hydra dermabrasion by using patented Vortex-Fusion Delivery Systems (Delivery Systems) to cleanse, extract, infuse, and hydrate the skin with solutions and serums. The Company has omnichannel place Delivery Systems where consumers live, work, and play, including medical offices, Medi spas, day spas, hotels, resorts, gyms, wellness centers, and other retail settings. HydraFacial is accessible and appropriate for consumers across all genders, ages, and skin types. It provides Keravive, which is a treatment designed to cleanse, exfoliate, and hydrate the scalp. HydraFacial is available in over 90 countries with an install base of approximately 25,000 Delivery Systems. Sector

HydraFacial Acquisitions

1 Acquisition

HydraFacial acquired 1 company. Their latest acquisition was Consulting Room on September 30, 2019.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

9/30/2019

$99M

Acquired

1

Date

9/30/2019

Investment Stage

Companies

Valuation

$99M

Total Funding

Note

Acquired

Sources

1

HydraFacial Partners & Customers

10 Partners and customers

HydraFacial has 10 strategic partners and customers. HydraFacial recently partnered with BABOR BEAUTY GROUP on December 12, 2022.

Date

Type

Business Partner

Country

News Snippet

Sources

12/7/2022

Partner

Germany

BeautyHealth’s Hydrafacial Launches New Booster Developed with BABOR Laboratories in Germany

`` DOCTOR BABOR is a world-renowned skincare brand known for their science-driven approach and rich European heritage , making them a natural collaborator for Hydrafacial . ''

1

11/4/2022

Partner

1

9/15/2022

Partner

United States

1

5/11/2022

Partner

United States

Subscribe to see more

Subscribe to see more

10

2/8/2021

Supplier

United States

Subscribe to see more

Subscribe to see more

10

Date

12/7/2022

11/4/2022

9/15/2022

5/11/2022

2/8/2021

Type

Partner

Partner

Partner

Partner

Supplier

Business Partner

Country

Germany

United States

United States

United States

News Snippet

BeautyHealth’s Hydrafacial Launches New Booster Developed with BABOR Laboratories in Germany

`` DOCTOR BABOR is a world-renowned skincare brand known for their science-driven approach and rich European heritage , making them a natural collaborator for Hydrafacial . ''

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

1

1

10

10

HydraFacial Team

9 Team Members

HydraFacial has 9 team members, including current Chief Executive Officer, Brent L. Saunders.

Name

Work History

Title

Status

Brent L. Saunders

Chief Executive Officer

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Brent L. Saunders

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Chief Executive Officer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.